ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases

Recruiting Observational Study
Metastatic Colorectal Cancer Circulating Tumor DNA
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
232 (estimated)
Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a prospective multicenter cohort study, was designed to explore the prognostic value of ctDNA as a biomarker of disease response and recurrence or death in patients undergoing curative-intent surgical resection of Colorectal cancer liver metastasis.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria The patient will be included if: 1. Has signed informed consent form and is willing to comply with all study procedures and availability for the study duration, 2. Is ≥ 18 years of age, 3. Has histologically confirmed colorectal adenocarcinoma, 4. Has resected primary tumor or i…
Contacts

Maximiliano GELLI, MD

+33(0)1 40 29 85 00

maximiliano.gelli@gustaveroussy.fr

CONTACT

Marie Line GARCIA, MD

+33(0)1 40 29 85 00

marie-line.garcia-larnicol@gercor.com.fr

CONTACT